Volume 12, Issue 1

Search all Infectious Diseases and Therapy articles

January 2023

24 articles in this issue

The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660
Robert Orenstein
Commentary Open access 07 November 2022 Pages: 1 - 7
Part of 1 collection:

Digital Features - Infectious Diseases
The Value of Rotavirus Vaccination in Europe: A Call for Action
Robert Cohen
Federico Martinón-Torres
Dirk Poelaert
Commentary Open access 10 November 2022 Pages: 9 - 29
Part of 1 collection:

Digital Features - Infectious Diseases
Publisher Correction: The Value of Rotavirus Vaccination in Europe: A Call for Action
Robert Cohen
Federico Martinón-Torres
Dirk Poelaert
Publisher Correction Open access 10 December 2022 Pages: 31 - 32
Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review
Myriam Drysdale
Lionel Tan
Hema Sharma
Review Open access 15 November 2022 Pages: 33 - 51
Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review
Yuting Diao
Juan Tang
Chunfang You
Review Open access 27 November 2022 Pages: 53 - 66
Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis
Yani Ke
Kaihan Wu
Shan Liu
Review Open access 28 November 2022 Pages: 67 - 80
Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature
Selim Badur
Onur Ozudogru
Adriana Guzman-Holst
Review Open access 03 December 2022 Pages: 81 - 93
Part of 1 collection:

Digital Features - Infectious Diseases
Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System
Lauren F. McDaniel
Melissa N. White
Nathan A. Everson
Original Research Open access 19 July 2022 Pages: 95 - 107
Correction to: Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System
Lauren F. McDaniel
Melissa N. White
Nathan A. Everson
Correction Open access 02 December 2022 Pages: 109 - 110
Machine Learning Successfully Detects Patients with COVID-19 Prior to PCR Results and Predicts Their Survival Based on Standard Laboratory Parameters in an Observational Study
Filip Styrzynski
Damir Zhakparov
Katja Baerenfaller
Original Research Open access 04 November 2022 Pages: 111 - 129
Epidemiology of Herpes Zoster in Adults in Mexico: A Retrospective Database Analysis
Adriana Guzman-Holst
Maria Yolanda Cervantes-Apolinar
Gloria Huerta-Garcia
Original Research Open access 08 November 2022 Pages: 131 - 141
Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019)
Marta Corcuera-Munguia
Ruth Gil-Prieto
Angel Gil-de-Miguel
Original Research Open access 08 November 2022 Pages: 143 - 156
Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain
Federico Martinón-Torres
Ángel Gil de Miguel
Luis Lizán
Original Research Open access 11 November 2022 Pages: 157 - 175
Part of 1 collection:

Digital Features - Infectious Diseases
Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19
Imke Kirste
Sayuri Hortsch
Simon Jochum
Original Research Open access 15 November 2022 Pages: 177 - 191
Ceftolozane–Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment
Kosuke Yoshimura
Hiroki Ohge
Shinya Takahashi
Original Research Open access 24 November 2022 Pages: 193 - 207
Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer
Denise Marie A. Francisco
Liangliang Zhang
Pablo C. Okhuysen
Original Research Open access 28 November 2022 Pages: 209 - 225
Association Between Body Mass Index Variation and Early Mortality Among 834 Ethiopian Adults Living with HIV on ART: A Joint Modelling Approach
Animut Alebel
David Sibbritt
Daniel Demant
Original Research Open access 28 November 2022 Pages: 227 - 244
Efficacy of Efavirenz-Based Regimen in Antiretroviral-Naïve Patients with HIV-1 V179D/E Mutations in Shanghai, China
Zhenyan Wang
Min Zhang
Hongzhou Lu
Original Research Open access 28 November 2022 Pages: 245 - 255
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience
Giusy Tiseo
Chiara Barbieri
Marco Falcone
Original Research Open access 28 November 2022 Pages: 257 - 271
Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study
Natàlia Pallarès
Cristian Tebé
the MetroSud and Divine study groups
Original Research Open access 10 December 2022 Pages: 273 - 289
Letter to the Editor Regarding “Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age”
Kristen Feemster
Thomas Weiss
Letter Open access 14 November 2022 Pages: 291 - 294
A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’
Mark H. Rozenbaum
Johnna Perdrizet
Raymond A. Farkouh
Letter Open access 14 November 2022 Pages: 295 - 298
Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia
Shun Ito
Masahiro Banno
Yuji Okazaki
Letter Open access 22 November 2022 Pages: 299 - 300
Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia”
Flavio Mantelli
Letter Open access 22 November 2022 Pages: 301 - 302

Volume 12, Issue 1

The Role of Microbiome-Based Therapeutics in Clostridioides difficile Infection: Durable, Long-Term Results of RBX2660

The Value of Rotavirus Vaccination in Europe: A Call for Action

Publisher Correction: The Value of Rotavirus Vaccination in Europe: A Call for Action

Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review

Metabolic Syndrome, Nonalcoholic Fatty Liver Disease, and Chronic Hepatitis B: A Narrative Review

Clinical Utility of Circulating Pentraxin 3 as a Prognostic Biomarker in Coronavirus Disease 2019: A Systematic Review and Meta-analysis

Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries: A Review of the Literature

Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System

Correction to: Clinical and Economic Outcomes After Implementation of a Fidaxomicin Treatment Optimization and Access Pathway at a US Hospital System

Machine Learning Successfully Detects Patients with COVID-19 Prior to PCR Results and Predicts Their Survival Based on Standard Laboratory Parameters in an Observational Study

Epidemiology of Herpes Zoster in Adults in Mexico: A Retrospective Database Analysis

Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019)

Societal Preferences for Meningococcal B Vaccination in Children: A Discrete Choice Experiment in Spain

Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19

Ceftolozane–Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment

Risk Factors Associated with Severe Clostridioides difficile Infection in Patients with Cancer

Association Between Body Mass Index Variation and Early Mortality Among 834 Ethiopian Adults Living with HIV on ART: A Joint Modelling Approach

Efficacy of Efavirenz-Based Regimen in Antiretroviral-Naïve Patients with HIV-1 V179D/E Mutations in Shanghai, China

Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience

Characteristics and Outcomes by Ceiling of Care of Subjects Hospitalized with COVID-19 During Four Waves of the Pandemic in a Metropolitan Area: A Multicenter Cohort Study

Letter to the Editor Regarding “Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age”

A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’

Letter to the Editor Regarding a Multicentric Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia

Response to “Letter to the Editor Regarding a Multicenter Phase 2 Randomized Controlled Study on the Efficacy and Safety of Reparixin in the Treatment of Hospitalized Patients with COVID-19 Pneumonia”

Navigation